Titre : bêta-Glucanes

bêta-Glucanes : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment diagnostiquer une carence en bêta-glucanes ?

Il n'existe pas de test spécifique, mais une évaluation nutritionnelle peut aider.
Carence nutritionnelle Bêta-glucanes
#2

Quels tests peuvent évaluer l'effet des bêta-glucanes ?

Des tests sanguins peuvent mesurer les niveaux de cholestérol et d'inflammation.
Cholestérol Inflammation

Symptômes 2

#1

Quels symptômes indiquent un manque de bêta-glucanes ?

Fatigue, immunité affaiblie et problèmes digestifs peuvent survenir.
Fatigue Immunité
#2

Les bêta-glucanes causent-ils des effets secondaires ?

Ils sont généralement bien tolérés, mais peuvent provoquer des troubles digestifs chez certains.
Effets secondaires Troubles digestifs

Prévention 2

#1

Comment intégrer les bêta-glucanes dans l'alimentation ?

Consommez des aliments riches comme l'avoine, l'orge et certains champignons.
Alimentation Avoine
#2

Les bêta-glucanes aident-ils à prévenir les maladies ?

Oui, ils peuvent réduire le risque de maladies cardiovasculaires et renforcer l'immunité.
Maladies cardiovasculaires Prévention

Traitements 2

#1

Comment les bêta-glucanes sont-ils utilisés en médecine ?

Ils sont utilisés comme suppléments pour renforcer le système immunitaire et réduire le cholestérol.
Suppléments alimentaires Système immunitaire
#2

Les bêta-glucanes peuvent-ils traiter le cancer ?

Ils sont étudiés pour leurs effets immunomodulateurs, mais ne remplacent pas les traitements conventionnels.
Cancer Immunomodulation

Complications 2

#1

Quelles complications peuvent survenir avec un excès de bêta-glucanes ?

Un excès peut entraîner des troubles digestifs comme des ballonnements ou des diarrhées.
Ballonnements Diarrhée
#2

Les bêta-glucanes interagissent-ils avec des médicaments ?

Ils peuvent interagir avec des anticoagulants, il est donc conseillé de consulter un médecin.
Anticoagulants Interactions médicamenteuses

Facteurs de risque 2

#1

Qui est à risque de carence en bêta-glucanes ?

Les personnes ayant une alimentation pauvre en fibres et en céréales complètes sont à risque.
Carence Fibres alimentaires
#2

Les personnes âgées ont-elles besoin de plus de bêta-glucanes ?

Oui, elles peuvent bénéficier d'une supplémentation pour soutenir leur immunité.
Personnes âgées Immunité
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "bêta-Glucanes : Questions médicales les plus fréquentes", "headline": "bêta-Glucanes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les bêta-Glucanes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-28", "dateModified": "2025-12-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "bêta-Glucanes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Glucanes", "url": "https://questionsmedicales.fr/mesh/D005936", "about": { "@type": "MedicalCondition", "name": "Glucanes", "code": { "@type": "MedicalCode", "code": "D005936", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.698.365" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lentinane", "alternateName": "Lentinan", "url": "https://questionsmedicales.fr/mesh/D007912", "about": { "@type": "MedicalCondition", "name": "Lentinane", "code": { "@type": "MedicalCode", "code": "D007912", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.698.365.089.500" } } }, { "@type": "MedicalWebPage", "name": "Schizophyllane", "alternateName": "Sizofiran", "url": "https://questionsmedicales.fr/mesh/D012566", "about": { "@type": "MedicalCondition", "name": "Schizophyllane", "code": { "@type": "MedicalCode", "code": "D012566", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.698.365.089.625" } } }, { "@type": "MedicalWebPage", "name": "Zymosan", "alternateName": "Zymosan", "url": "https://questionsmedicales.fr/mesh/D015054", "about": { "@type": "MedicalCondition", "name": "Zymosan", "code": { "@type": "MedicalCode", "code": "D015054", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.698.365.089.750" } } } ], "about": { "@type": "MedicalCondition", "name": "bêta-Glucanes", "alternateName": "beta-Glucans", "code": { "@type": "MedicalCode", "code": "D047071", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Malgorzata Mikulska", "url": "https://questionsmedicales.fr/author/Malgorzata%20Mikulska", "affiliation": { "@type": "Organization", "name": "Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy." } }, { "@type": "Person", "name": "Joanna Harasym", "url": "https://questionsmedicales.fr/author/Joanna%20Harasym", "affiliation": { "@type": "Organization", "name": "Adaptive Food Systems Accelerator-Research Centre, Wroclaw University of Economics and Business, Komandorska 118/120, 53-345 Wrocław, Poland." } }, { "@type": "Person", "name": "Jacek Wilczak", "url": "https://questionsmedicales.fr/author/Jacek%20Wilczak", "affiliation": { "@type": "Organization", "name": "Department of Physiological Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences (SGGW-WULS), Nowoursynowska 159, 02-776 Warsaw, Poland." } }, { "@type": "Person", "name": "Katarzyna Dziendzikowska", "url": "https://questionsmedicales.fr/author/Katarzyna%20Dziendzikowska", "affiliation": { "@type": "Organization", "name": "Department of Dietetics, Institute of Human Nutrition Sciences, Warsaw University of Life Sciences (SGGW-WULS), Nowoursynowska 159c, 02-776 Warsaw, Poland." } }, { "@type": "Person", "name": "Joanna Gromadzka-Ostrowska", "url": "https://questionsmedicales.fr/author/Joanna%20Gromadzka-Ostrowska", "affiliation": { "@type": "Organization", "name": "Department of Dietetics, Institute of Human Nutrition Sciences, Warsaw University of Life Sciences (SGGW-WULS), Nowoursynowska 159c, 02-776 Warsaw, Poland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Development of a scalable recombinant system for cyclic beta-1,2-glucans production.", "datePublished": "2024-05-06", "url": "https://questionsmedicales.fr/article/38711033", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12934-024-02407-z" } }, { "@type": "ScholarlyArticle", "name": "Optimizing the synthesis of yeast Beta-glucan via response surface methodology for nanotechnology application.", "datePublished": "2023-04-20", "url": "https://questionsmedicales.fr/article/37081407", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12866-023-02845-6" } }, { "@type": "ScholarlyArticle", "name": "Beta glucan as an immune stimulant in tumor microenvironment - Insight into lessons and promises from past decade.", "datePublished": "2023-02-08", "url": "https://questionsmedicales.fr/article/36758755", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijbiomac.2023.123617" } }, { "@type": "ScholarlyArticle", "name": "Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management.", "datePublished": "2023-03-08", "url": "https://questionsmedicales.fr/article/36906407", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.vaccine.2023.03.005" } }, { "@type": "ScholarlyArticle", "name": "Differences in Ratio of Carbon Stable Isotopes among Barley Grain Milling Fractions with Various Concentrations of Beta-Glucans.", "datePublished": "2023-07-29", "url": "https://questionsmedicales.fr/article/37570708", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/molecules28155738" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Glucides", "item": "https://questionsmedicales.fr/mesh/D002241" }, { "@type": "ListItem", "position": 3, "name": "Polyosides", "item": "https://questionsmedicales.fr/mesh/D011134" }, { "@type": "ListItem", "position": 4, "name": "Glucanes", "item": "https://questionsmedicales.fr/mesh/D005936" }, { "@type": "ListItem", "position": 5, "name": "bêta-Glucanes", "item": "https://questionsmedicales.fr/mesh/D047071" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : bêta-Glucanes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur bêta-Glucanes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-02-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur bêta-Glucanes", "description": "Comment diagnostiquer une carence en bêta-glucanes ?\nQuels tests peuvent évaluer l'effet des bêta-glucanes ?", "url": "https://questionsmedicales.fr/mesh/D047071#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur bêta-Glucanes", "description": "Quels symptômes indiquent un manque de bêta-glucanes ?\nLes bêta-glucanes causent-ils des effets secondaires ?", "url": "https://questionsmedicales.fr/mesh/D047071#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur bêta-Glucanes", "description": "Comment intégrer les bêta-glucanes dans l'alimentation ?\nLes bêta-glucanes aident-ils à prévenir les maladies ?", "url": "https://questionsmedicales.fr/mesh/D047071#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur bêta-Glucanes", "description": "Comment les bêta-glucanes sont-ils utilisés en médecine ?\nLes bêta-glucanes peuvent-ils traiter le cancer ?", "url": "https://questionsmedicales.fr/mesh/D047071#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur bêta-Glucanes", "description": "Quelles complications peuvent survenir avec un excès de bêta-glucanes ?\nLes bêta-glucanes interagissent-ils avec des médicaments ?", "url": "https://questionsmedicales.fr/mesh/D047071#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur bêta-Glucanes", "description": "Qui est à risque de carence en bêta-glucanes ?\nLes personnes âgées ont-elles besoin de plus de bêta-glucanes ?", "url": "https://questionsmedicales.fr/mesh/D047071#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence en bêta-glucanes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de test spécifique, mais une évaluation nutritionnelle peut aider." } }, { "@type": "Question", "name": "Quels tests peuvent évaluer l'effet des bêta-glucanes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins peuvent mesurer les niveaux de cholestérol et d'inflammation." } }, { "@type": "Question", "name": "Quels symptômes indiquent un manque de bêta-glucanes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, immunité affaiblie et problèmes digestifs peuvent survenir." } }, { "@type": "Question", "name": "Les bêta-glucanes causent-ils des effets secondaires ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont généralement bien tolérés, mais peuvent provoquer des troubles digestifs chez certains." } }, { "@type": "Question", "name": "Comment intégrer les bêta-glucanes dans l'alimentation ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Consommez des aliments riches comme l'avoine, l'orge et certains champignons." } }, { "@type": "Question", "name": "Les bêta-glucanes aident-ils à prévenir les maladies ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent réduire le risque de maladies cardiovasculaires et renforcer l'immunité." } }, { "@type": "Question", "name": "Comment les bêta-glucanes sont-ils utilisés en médecine ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont utilisés comme suppléments pour renforcer le système immunitaire et réduire le cholestérol." } }, { "@type": "Question", "name": "Les bêta-glucanes peuvent-ils traiter le cancer ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont étudiés pour leurs effets immunomodulateurs, mais ne remplacent pas les traitements conventionnels." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec un excès de bêta-glucanes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Un excès peut entraîner des troubles digestifs comme des ballonnements ou des diarrhées." } }, { "@type": "Question", "name": "Les bêta-glucanes interagissent-ils avec des médicaments ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent interagir avec des anticoagulants, il est donc conseillé de consulter un médecin." } }, { "@type": "Question", "name": "Qui est à risque de carence en bêta-glucanes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant une alimentation pauvre en fibres et en céréales complètes sont à risque." } }, { "@type": "Question", "name": "Les personnes âgées ont-elles besoin de plus de bêta-glucanes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent bénéficier d'une supplémentation pour soutenir leur immunité." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 18/12/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Malgorzata Mikulska

3 publications dans cette catégorie

Affiliations :
  • Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy.
  • Division of Infectious Diseases, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.
Publications dans "bêta-Glucanes" :

Joanna Harasym

3 publications dans cette catégorie

Affiliations :
  • Adaptive Food Systems Accelerator-Research Centre, Wroclaw University of Economics and Business, Komandorska 118/120, 53-345 Wrocław, Poland.
  • Department of Biotechnology and Food Analysis, Wroclaw University of Economics and Business, Komandorska 118/120, 53-345 Wrocław, Poland.

Jacek Wilczak

3 publications dans cette catégorie

Affiliations :
  • Department of Physiological Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences (SGGW-WULS), Nowoursynowska 159, 02-776 Warsaw, Poland.

Katarzyna Dziendzikowska

3 publications dans cette catégorie

Affiliations :
  • Department of Dietetics, Institute of Human Nutrition Sciences, Warsaw University of Life Sciences (SGGW-WULS), Nowoursynowska 159c, 02-776 Warsaw, Poland.

Joanna Gromadzka-Ostrowska

3 publications dans cette catégorie

Affiliations :
  • Department of Dietetics, Institute of Human Nutrition Sciences, Warsaw University of Life Sciences (SGGW-WULS), Nowoursynowska 159c, 02-776 Warsaw, Poland.

Peerapat Visitchanakun

2 publications dans cette catégorie

Affiliations :
  • Center of Excellence on Translational Research in Inflammation and Immunology (CETRII), Department of Microbiology, Chulalongkorn University, Bangkok 10330, Thailand.
  • Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Publications dans "bêta-Glucanes" :

Asada Leelahavanichkul

2 publications dans cette catégorie

Affiliations :
  • Center of Excellence on Translational Research in Inflammation and Immunology (CETRII), Department of Microbiology, Chulalongkorn University, Bangkok 10330, Thailand.
  • Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
  • Nephrology Unit, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Publications dans "bêta-Glucanes" :

Toine Mercier

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium toine.mercier@uzleuven.be.
  • Department of Hematology, University Hospitals Leuven, Leuven, Belgium.
Publications dans "bêta-Glucanes" :

Johan Maertens

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Department of Hematology, University Hospitals Leuven, Leuven, Belgium.
Publications dans "bêta-Glucanes" :

Malcolm Finkelman

2 publications dans cette catégorie

Affiliations :
  • Clinical Development, Associates of Cape Cod, Inc, Falmouth, MA, USA.

Yonglong Zhang

2 publications dans cette catégorie

Affiliations :
  • Clinical Development, Associates of Cape Cod, Inc, Falmouth, MA, USA.

Barry W Neun

2 publications dans cette catégorie

Affiliations :
  • Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Publications dans "bêta-Glucanes" :

Marina A Dobrovolskaia

2 publications dans cette catégorie

Affiliations :
  • Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. marina@mail.nih.gov.
Publications dans "bêta-Glucanes" :

Laura Magnasco

2 publications dans cette catégorie

Affiliations :
  • Division of Infectious Diseases, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy.
Publications dans "bêta-Glucanes" :

Antonio Vena

2 publications dans cette catégorie

Affiliations :
  • Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy.
  • Division of Infectious Diseases, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy.
Publications dans "bêta-Glucanes" :

Anna Marchese

2 publications dans cette catégorie

Affiliations :
  • Microbiology Unit, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy.
  • Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, 16132 Genoa, Italy.
Publications dans "bêta-Glucanes" :

Daniele Roberto Giacobbe

2 publications dans cette catégorie

Affiliations :
  • Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy.
  • Division of Infectious Diseases, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy.
Publications dans "bêta-Glucanes" :

Matteo Bassetti

2 publications dans cette catégorie

Affiliations :
  • Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy.
  • Division of Infectious Diseases, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, 16132 Genoa, Italy.
Publications dans "bêta-Glucanes" :

Iwona Mirończuk-Chodakowska

2 publications dans cette catégorie

Affiliations :
  • Department of Food Biotechnology, Faculty of Health Sciences, Medical University of Bialystok, Szpitalna 37, 15-295 Bialystok, Poland.
Publications dans "bêta-Glucanes" :

Anna Maria Witkowska

2 publications dans cette catégorie

Affiliations :
  • Department of Food Biotechnology, Faculty of Health Sciences, Medical University of Bialystok, Szpitalna 37, 15-295 Bialystok, Poland.
Publications dans "bêta-Glucanes" :

Sources (3068 au total)

Development of a scalable recombinant system for cyclic beta-1,2-glucans production.

Cyclic β-1,2-glucans (CβG) are bacterial cyclic homopolysaccharides with interesting biotechnological applications. These ring-shaped molecules have a hydrophilic surface that confers high solubility ... We present the production of CβG in specially designed E. coli strains by means of the deletion of intrinsic polysaccharide biosynthetic genes and the heterologous expression of enzymes involved in Cβ... We have developed a new recombinant bacterial system for the synthesis of cyclic β-1,2-glucans, expanding the use of bacteria as a platform for the production of new polysaccharides with biotechnologi...

Optimizing the synthesis of yeast Beta-glucan via response surface methodology for nanotechnology application.

The production of biopolymers from waste resources is a growing trend, especially in high-population countries like Egypt. Beta-glucan (β-glucan) belongs to natural polysaccharides that are derived fr... Ingredients of low-cost media based on agro-industrial wastes were described using Plackett-Burman and central composite design of response surface methodology for optimizing yeast β-glucan. Minerals ... Enriching the low-cost media based on agro-industrial wastes with nutritional ingredients improves the yield of yeast β-glucan. The present study succeeds to form β-glucan nanoparticles by a simple me...

Effect of brewer's yeast or beta-glucan on breast milk supply following preterm birth: the BLOOM study - protocol for a multicentre randomised controlled trial.

Many individuals who experience preterm birth struggle with early breast milk supply, which can translate into suboptimal longer-term breastfeeding outcomes. Further investigations into the potential ... The BLOOM study is a multicentre, double-blinded, randomised controlled trial that will assess if brewer's yeast or beta-glucan can increase early breast milk production following preterm birth. Targe... The use of brewer's yeast as a galactagogue to enhance milk production is extremely common amongst breastfeeding mothers, however, there are no trials evaluating its efficacy and safety. This will be ... Australian and New Zealand Clinical Trials Registry ACTRN12622000968774 (registered on 8 July 2022) and UTN U1111-1278-8827....

Yeast Beta-Glucan Supplementation with Multivitamins Attenuates Cognitive Impairments in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.

This research aimed to examine the potential alleviative effects of beta-glucan administration on fatigue, unrefreshing sleep, anxiety/depression symptoms and health-related quality of life in ME/CFS....

Combination of serum and peritoneal 1.3-beta-D-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective study.

Intra-abdominal candidiasis (IAC) is difficult to predict in critically ill patients with intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and peritoneal 1.3-beta-D-gl... This prospective multicenter noninterventional French study included consecutive critically ill patients undergoing abdominal surgery for abdominal sepsis. The primary objective was to establish the I... Between 1 January 2020 and 31 December 2022, 199 patients were included. Patients were predominantly male (63%), with a median age of 66 [54-72] years. The IAC prevalence was 44% (87/199). The main IA... In critically ill patients with intra-abdominal infection requiring surgery, the IAC prevalence was 44%. Combining low sBDG and pBDG with a low peritonitis score effectively excluded IAC and could lim... The study was registered with ClinicalTrials.gov (ID number 03997929, first registered on June 24, 2019)....

Adherence and impact of an oral nutritional supplement enriched in leucine, EVOO, EPA and DHA, and beta-glucans on the coverage of energy and protein requirements in patients with cancer and malnutrition: Alisenoc study.

The aim of this study was to evaluate the impact of an enhanced ONS (enriched in EPA, DHA, leucine, and beta-glucans) on the dietary intake of cancer patients.... A randomized, double-blind, parallel, controlled, and multicenter clinical trial was conducted in patients with cancer and malnutrition. The trial compared prescribed dietary advice and two packs per ... Thirty-seven patients completed the intervention period. The combined intervention of dietary advice and ONS managed to increase the energy intake of the overall cohort by 792.55 (378.57) kcal/day, pr... The use of an enhanced-ONS helps meet the nutritional requirements of cancer patients, especially those who have a more compromised clinical condition, with high adherence, good tolerance, and accepta...